STRM

Streamline Health Solutions, Inc. (STRM) SWOT Analysis Analysis (2026)

Invetso Score: 3.4/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.2 (Moderate)

Cash conversion cycle is positive at 5.5 days, indicating working-capital discipline relative to peers that often carry longer cash cycles in capital-intensive distribution.

Debt-to-equity of 1.07 suggests leverage is manageable versus highly levered peers, supporting some financial flexibility despite weaker profitability.

Net debt to EBITDA is negative at -3.3, implying net cash positioning that compares favorably with peers reliant on debt-funded operations.

The company’s asset-light cash profile can partially offset weak returns, because peers with heavier fixed-asset bases typically face slower capital recovery.

Weaknesses

Score:

ROIC of -31.3% signals severe value destruction, leaving STRM structurally behind profitable peers that compound capital at positive returns.

Current and quick ratios of 0.25 indicate acute liquidity strain, which is materially weaker than peers with stronger short-term coverage.

Negative operating and gross margin data limit evidence of pricing power, while peers with stable margins can absorb demand shocks more effectively.

The combination of weak returns and thin liquidity constrains reinvestment capacity, making STRM less resilient than better-capitalized competitors.

Opportunities

Score:

Net cash balance provides room to stabilize operations, giving STRM more flexibility than indebted peers to fund working-capital needs.

If management improves capital efficiency, the low cash-conversion cycle could translate into faster internal funding than peers with slower turnover.

Any margin normalization would have outsized impact because current profitability is depressed, whereas peers with already healthy margins have less upside leverage.

A cleaner balance sheet can support strategic optionality versus leveraged peers, especially if industry conditions improve over the next two to five years.

Threats

Score:

Persistently negative ROIC raises the risk of continued capital erosion, while peers with positive returns can widen structural gaps over time.

Liquidity ratios below 1.0 increase refinancing and operating-stress risk, making STRM more vulnerable than peers with stronger current assets.

If margins remain unreported or weak, competitive pricing pressure could further compress economics versus peers with clearer cost advantages.

Limited financial cushion reduces resilience to demand softness, so peers with stronger balance sheets can defend share more effectively in downturns.

Overall Score

Score:

STRM’s net cash position and modest cash-cycle efficiency are offset by severe return on capital weakness and very tight liquidity, leaving it structurally below stronger peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Streamline Health Solutions, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →